Budget 2014: Will implementation live up to intent?
I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘India is crucial to us for the future’
With a 5.7 per cent growth in sales in 2013, Boehringer Ingelheim (BI) ranks seventh among its global peers but has a long way to…
Cipla plans investment in its UK subsidiary
The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines
Actavis completes acquisition of Forest Laboratories
Creates an innovative new model in speciality pharma leadership
Merck Serono’s grants programme to fund scientific innovation
The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education
Bharat Biotech donates REGEN-D to victims of AP gas explosion
Donates 500 tubes of REGEN-D to AP CM’s Relief Fund
Glenmark Generics receives ANDA approval
Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis
Focus on complementary products to develop existing portfolio drives M&A activity
M&A activity in the pharmaceutical sector was focused on advancing the development of promising products through complementary…
Conference on ‘Innovations in Oral Drug Delivery Systems’ held in Mumbai
Organised by Infinity Business Services and supported by I3R Global, the conference aimed to highlight the latest trends and…